Comparing wood production and carbon sequestration after extreme thinnings in boreal Scots pine stands

Fennoscandian studies of thinning responses are usually limited to low thinning with moderate intensities. We studied here intermediate commercial thinning of different types (low, crown/normal, crown/strict, where respectively mostly intermediate and suppressed trees, mostly dominant and co-dominant trees, and only dominant trees were removed) and intensities (moderate and heavy) in Scots pine (Pinus sylvestris L.) dominated stands. We analysed their responses in terms of wood production and carbon balance. We investigated three stands in Southern and Middle Finland at the stage of second or third commercial thinning (age 34–50 years). We observed their development for fifteen years, and then we further simulated it with MOTTI stand simulator until final felling (scheduled either at age 65 or 80 years). We considered various variables of interest related to the thinning outputs, volume production after thinning, simulated final felling, and carbon balance. For all variables of interest, there were negligible differences across thinning types, and strong ones across thinning intensities. Thinning removals were significantly higher in heavy than moderate treatments, although only crown heavy thinnings had significantly higher sawlog output than low moderate. Volume growth post thinning during the 15-years observation was highest in unthinned plots, followed by moderate and then heavy treatments. For both total standing volume at simulated final fellings and carbon balance at any times, there was a similar descending trend from unthinned to moderate to heavy treatments. Concluding, the results suggest that crown/normal thinning could be applied with moderate intensity as alternative to low thinning, while heavy thinnings do not provide commercial benefits in Scots pine stands. Heavy intermediate thinnings in Scots pine stands provides lower total carbon accumulation during rotation, and early higher wood products (although not necessarily in terms of sawlogs) at the expense of later ones. Moderate thinning reached on site carbon neutrality after 5-years, while heavy thinning after 15 years

On the importance of chain branching in tear film lipid layer wax and cholesteryl esters

The tear film lipid layer (TFLL) is important to the maintenance of ocular surface health. Surprisingly, information on the individual roles of the myriad of unique lipids found therein is limited. The most abundant lipid species are the wax esters (WE) and cholesteryl esters (CE), and, especially their branched analogs. The isolation of these lipid species from the TFLL has proved to be tedious, and as a result, insights on their biophysical profiles and role in the TFLL is currently lacking. Herein, we circumvent these issues by a total synthesis of the most abundant iso-methyl branched WEs and CEs found in the TFLL. Through a detailed characterization of the biophysical properties, by the use of Langmuir monolayer and wide-angle X-ray scattering techniques, we demonstrate that chain branching alters the behavior of these lipid species on multiple levels. Taken together, our results fill an important knowledge gap concerning the structure and function of the TFLL on the whole.Peer reviewe

A systematic review of school-based interventions targeting physical activity and sedentary behaviour among older adolescents.

This is the final version of the article. It was first available from Taylor & Francis via http://dx.doi.org/10.1080/1750984X.2015.1081706Lack of physical activity (PA) and high levels of sedentary behaviour (SB) have been associated with health problems. This systematic review evaluates the effectiveness of school-based interventions to increase PA and decrease SB among 15-19-year-old adolescents, and examines whether intervention characteristics (intervention length, delivery mode and intervention provider) and intervention content (i.e. behaviour change techniques, BCTs) are related to intervention effectiveness. A systematic search of randomised or cluster randomised controlled trials with outcome measures of PA and/or SB rendered 10 results. Risk of bias was assessed using the Cochrane risk of bias tool. Intervention content was coded using Behaviour Change Technique Taxonomy v1. Seven out of 10 studies reported significant increases in PA. Effects were generally small and short-term (Cohen's d ranged from 0.132 to 0.659). Two out of four studies that measured SB reported significant reductions in SB. Interventions that increased PA included a higher number of BCTs, specific BCTs (e.g., goal setting, action planning and self-monitoring), and were delivered by research staff. Intervention length and mode of delivery were unrelated to effectiveness. More studies are needed that evaluate long-term intervention effectiveness and target SBs among older adolescents

Overview of Therapeutic Ultrasound Applications and Safety Considerations

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/135598/1/jum2012314623.pd

Ultrasound-Enhanced Drug Transport and Distribution in the Brain

Drug delivery in the brain is limited by slow drug diffusion in the brain tissue. This study tested the hypothesis that ultrasound can safely enhance the permeation of drugs in the brain. In vitro exposure to ultrasound at various frequencies (85 kHz, 174 kHz, and 1 MHz) enhanced the permeation of tritium-labeled molecules with molecular weight up to 70 kDa across porcine brain tissue. A maximum enhancement of 24-fold was observed at 85 kHz and 1,200 J/cm2. In vivo exposure to 1-MHz ultrasound further demonstrated the ability of ultrasound to facilitate molecule distribution in the brain of a non-human primate. Finally, ultrasound under conditions similar to those used in vivo was shown to cause no damage to plasmid DNA, siRNA, adeno-associated virus, and fetal rat cortical neurons over a range of conditions. Altogether, these studies demonstrate that ultrasound can increase drug permeation in the brain in vitro and in vivo under conditions that did not cause detectable damage

Targeted Delivery of Neural Stem Cells to the Brain Using MRI-Guided Focused Ultrasound to Disrupt the Blood-Brain Barrier

Stem cell therapy is a promising strategy to treat neurodegenerative diseases, traumatic brain injury, and stroke. For stem cells to progress towards clinical use, the risks associated with invasive intracranial surgery used to deliver the cells to the brain, needs to be reduced. Here, we show that MRI-guided focused ultrasound (MRIgFUS) is a novel method for non-invasive delivery of stem cells from the blood to the brain by opening the blood brain barrier (BBB) in specific brain regions. We used MRI guidance to target the ultrasound beam thereby delivering the iron-labeled, green fluorescent protein (GFP)-expressing neural stem cells specifically to the striatum and the hippocampus of the rat brain. Detection of cellular iron using MRI established that the cells crossed the BBB to enter the brain. After sacrifice, 24 hours later, immunohistochemical analysis confirmed the presence of GFP-positive cells in the targeted brain regions. We determined that the neural stem cells expressed common stem cell markers (nestin and polysialic acid) suggesting they survived after transplantation with MRIgFUS. Furthermore, delivered stem cells expressed doublecortin in vivo indicating the stem cells were capable of differentiating into neurons. Together, we demonstrate that transient opening of the BBB with MRIgFUS is sufficient for transplantation of stem cells from the blood to targeted brain structures. These results suggest that MRIgFUS may be an effective alternative to invasive intracranial surgery for stem cell transplantation

Individual tree basal area increment models suitable for different stand structures in Finland

Forest growth models employed in Fennoscandia have been generally targeted at rotation forestry (RF) stands, relying on age as a key predictor. Uneven aged, irregular stands, such as the ones managed with continuous cover forestry, are becoming of increasingly common. New models suited for all kind of management approaches (i.e., age-independent) have been developed in Fennoscandia. Although the ongoing climate change is projected to strongly affect tree growth in boreal regions, climatic variables included in current models are usually restricted to temperature sum averages with simple links. The objectives of our research were: 1) fitting a new age independent empirical tree basal area increment model (B2023) with inclusion of additional climatic variables for the main Nordic tree species (Norway spruce, Scots pine, and birches); 2) using independent data to validate both the new model and other two age-independent published empirical models (P2013, P2021); and 3) investigating the sensitivity of growth predictions of all the empirical models to climate change. Our results showed that the new model B2023 was as accurate as P2013 when independently validated. Both models performed well in different forest structures and management alternatives (namely rotation forestry, continuous cover forestry, two-storied stands, and old-growth natural forests), although with few differences, and on average slightly better than P2021. At plot level, the new model B2023 showed slight underprediction for the overstorey pine layer in continuous cover forestry and two-storied stands. The predicted climate change scenarios increased simulated growth in all models, although P2021 showed very high values for spruce. We failed to include additional climatic variables than temperature sum in B2023, thus not improving much its accuracy under historical data, nor its sensitivity to future climate. Concluding, the individual tree models here presented can be applied to a wide range of forest structures and managements in Fennoscandia. For long-term simulation scenarios, different approaches to improve the climate sensitivity of empirical, individual tree model should be explored

Ultrasound-Responsive Cavitation Nuclei for Therapy and Drug Delivery

Therapeutic ultrasound strategies that harness the mechanical activity of cavitation nuclei for beneficial tissue bio-effects are actively under development. The mechanical oscillations of circulating microbubbles, the most widely investigated cavitation nuclei, which may also encapsulate or shield a therapeutic agent in the bloodstream, trigger and promote localized uptake. Oscillating microbubbles can create stresses either on nearby tissue or in surrounding fluid to enhance drug penetration and efficacy in the brain, spinal cord, vasculature, immune system, biofilm or tumors. This review summarizes recent investigations that have elucidated interactions of ultrasound and cavitation nuclei with cells, the treatment of tumors, immunotherapy, the blood–brain and blood–spinal cord barriers, sonothrombolysis, cardiovascular drug delivery and sonobactericide. In particular, an overview of salient ultrasound features, drug delivery vehicles, therapeutic transport routes and pre-clinical and clinical studies is provided. Successful implementation of ultrasound and cavitation nuclei-mediated drug delivery has the potential to change the way drugs are administered systemically, resulting in more effective therapeutics and less-invasive treatments

Noninvasive, Transient and Selective Blood-Brain Barrier Opening in Non-Human Primates In Vivo

The blood-brain barrier (BBB) is a specialized vascular system that impedes entry of all large and the vast majority of small molecules including the most potent central nervous system (CNS) disease therapeutic agents from entering from the lumen into the brain parenchyma. Microbubble-enhanced, focused ultrasound (ME-FUS) has been previously shown to disrupt noninvasively, selectively, and transiently the BBB in small animals in vivo. For the first time, the feasibility of transcranial ME-FUS BBB opening in non-human primates is demonstrated with subsequent BBB recovery. Sonications were combined with two different types of microbubbles (customized 4–5 µm and Definity®). 3T MRI was used to confirm the BBB disruption and to assess brain damage